1. Home
  2. DRMA vs SOPA Comparison

DRMA vs SOPA Comparison

Compare DRMA & SOPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DRMA
  • SOPA
  • Stock Information
  • Founded
  • DRMA 2014
  • SOPA 2018
  • Country
  • DRMA United States
  • SOPA Singapore
  • Employees
  • DRMA N/A
  • SOPA N/A
  • Industry
  • DRMA Biotechnology: Pharmaceutical Preparations
  • SOPA EDP Services
  • Sector
  • DRMA Health Care
  • SOPA Technology
  • Exchange
  • DRMA Nasdaq
  • SOPA Nasdaq
  • Market Cap
  • DRMA 6.1M
  • SOPA 6.3M
  • IPO Year
  • DRMA 2021
  • SOPA 2021
  • Fundamental
  • Price
  • DRMA $0.99
  • SOPA $0.82
  • Analyst Decision
  • DRMA Strong Buy
  • SOPA Buy
  • Analyst Count
  • DRMA 1
  • SOPA 2
  • Target Price
  • DRMA $6.00
  • SOPA $16.00
  • AVG Volume (30 Days)
  • DRMA 4.1M
  • SOPA 77.5K
  • Earning Date
  • DRMA 05-14-2025
  • SOPA 05-14-2025
  • Dividend Yield
  • DRMA N/A
  • SOPA N/A
  • EPS Growth
  • DRMA N/A
  • SOPA N/A
  • EPS
  • DRMA N/A
  • SOPA N/A
  • Revenue
  • DRMA N/A
  • SOPA $6,906,240.00
  • Revenue This Year
  • DRMA N/A
  • SOPA $7.97
  • Revenue Next Year
  • DRMA N/A
  • SOPA $15.61
  • P/E Ratio
  • DRMA N/A
  • SOPA N/A
  • Revenue Growth
  • DRMA N/A
  • SOPA N/A
  • 52 Week Low
  • DRMA $0.95
  • SOPA $0.73
  • 52 Week High
  • DRMA $6.66
  • SOPA $6.75
  • Technical
  • Relative Strength Index (RSI)
  • DRMA 35.86
  • SOPA 34.46
  • Support Level
  • DRMA $1.16
  • SOPA $1.10
  • Resistance Level
  • DRMA $2.37
  • SOPA $1.18
  • Average True Range (ATR)
  • DRMA 0.17
  • SOPA 0.08
  • MACD
  • DRMA -0.03
  • SOPA -0.01
  • Stochastic Oscillator
  • DRMA 2.86
  • SOPA 3.61

About DRMA Dermata Therapeutics Inc.

Dermata Therapeutics Inc is a clinical-stage medical dermatology company focused on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. Its two product candidates, DMT310 and DMT410, incorporate its proprietary, multifaceted, Spongilla technology to topically treat a variety of dermatological conditions. Its Spongilla technology platform will enable to develop and formulate singular and combination products that are able to target topical delivery of chemical compounds into the dermis for maximum treatment effect for a variety of inflammatory skin diseases.

About SOPA Society Pass Incorporated

Society Pass Inc is building an ecosystem of platforms and technology-enabled companies that synergistically work together to transform how consumers and merchants interact with one another in Southeast Asia and South Asia. Through the acquisition of companies and partnerships with visionary entrepreneurs, the company meets the growing demand for better services in sectors such as lifestyle, beauty, travel, and food and beverage. The company currently operates in Six reportable operating segments: Online Grocery and Food and grocery deliveries, Digital marketing, Online ticketing and reservation, Telecommunications Reseller, e-commerce, and Merchant Point of Sale (merchant POS). The company generates the majority of its revenue from the Digital marketing segment.

Share on Social Networks: